Story Poster
Texas A&M Football

Introducing TexAgs NIL Trading Cards featuring A&M student-athletes

September 9, 2022
27,443

Introducing TexAgs’ exclusive NIL trading cards featuring A&M student-athletes!

By purchasing these individual cards, not only will you get your own small piece of Texas A&M memorabilia, but you will also be able to support your favorite players through NIL as 100 percent of the proceeds will go directly to the student-athletes after accounting for printing costs, licensing costs, credit card fees, shipping, and packaging!

The first round of Texas A&M athletes to be featured will be running back Devon Achane, wide receiver Ainias Smith, and defensive back Antonio Johnson but other players, sports and special moments will be highlighted soon!

There are four different levels of cards that you can individually purchase:

  • Standard ($5) - Your Standard card is a TexAgs exclusive as you cannot find them anywhere else and will feature statistics, information and more about your favorite Aggies!
  • Silver ($25) - A step above the Standard cards, your Silver cards will come with a glossy, metallic finish and include the same information about your favorite player while supporting them to a larger degree.
  • Gold ($100) - As the name implies, the Gold series has a unique golden finish that might be fitting for a running back with world-class track speed. Once again, this level of trading card will include stats and other info regarding whichever player(s) you choose, but will also include a 100% AUTHENTIC autograph from the player!
  • Diamond Signature ($1,000) - There will be just 12 of these produced for each card design and not only will your Diamond Signature card come with a special ‘diamond’ finish as well as all of the perks listed above, including an authentic autograph from the player.

These cards are available for purchase NOW!

 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.